Intestinal Transplant Research and Publications
Intestinal Transplant Research That Continues to Improve Patient Care
UPMC is a leader in immunosuppressive therapy and other cutting-edge transplant research and advancements.
Our latest work focuses on reducing — or even eliminating, in a few cases — the need for antirejection medications to support long-term outcomes.
This includes pioneering recipient pretreatment (preconditioning) to prevent initial rejection, while reducing the need for high doses of antirejection medications with long-term follow-up.
Current Research Highlights